Antitrust Approval in China

Regulatory approval for an international acquisition


Brief Description / Context

A globally active DAX-listed corporation required approval from the Chinese antitrust authorities to legally complete the acquisition of an internationally active company. After approval was initially denied and the proceedings had reached an impasse, MEI WEN TI Managing Director Felix Kurz was brought into the process.


Challenge

The pending approval from the Chinese authorities jeopardized the successful completion of the international acquisition. In addition to regulatory complexity, political sensitivities, reliable communication channels, and significant time pressure played a decisive role.


Result

€1.8 billion
Value of the international acquisition
Approval granted
Approval from Chinese antitrust authorities
Resolved under time pressure
Strategic guidance in a sensitive regulatory environment


Scope of Services

  • Government Relations & Public Affairs
  • Strategic Consulting
  • International Communication
  • Project Support in the Regulatory Environment


Industry Focus

  • Pharmaceuticals
  • Manufacturing & International Corporate Structures


Role of MEI WEN TI

MEI WEN TI served as the strategic intermediary in the institutional environment and supported the process within the Chinese context, which required a high degree of political and regulatory sensitivity.